Tanawat Jongraksak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Results from the systematic review and meta-analysis demonstrated the positive effect of DAA therapy on overall survival, HCC-free survival, and liver function among patients with HCV decompensated cirrhosis compared to a non-DAA control group.

Tanawat jongraksakRamathibodi hospital at mahidol universityWorld health organizationEnd stage liver diseaseRamathibodi hospitalMahidol universityCochrane central registerControlled trialsCochrane riskNon randomized studiesDirect acting antiviralHepatitisc virusHepatocellular carcinomaLiver functionDecompensated cirrhosis